摘要
法尼醇X受体(farnesoid X receptor,FXR)属于核受体超家族,研究证明FXR可调控多种代谢通路,除在胆汁酸代谢中发挥重要作用外,FXR激活后参与维持机体糖脂代谢稳态。随着糖脂代谢异常相关疾病发病率的升高,FXR对糖脂代谢的调节越来越引起研究者的重视。FXR激动剂可能成为治疗2型糖尿病和脂代谢紊乱等代谢性疾病的新型药物靶点。
As a member of nuclear receptor superfamily, farnesoid X receptor (FXR) has been shown to regulate numerous metabolic pathways, which include playing an important role in bile acid metabolism, maintaining lipid and glucose homeostasis when FXR is activated. With the prevalence of the glucose and lipids disorder, FXR attracts increasing attention. It may be a potential target for the treatment of type 2 diabetes mellitus and lipid disorders.
出处
《药学学报》
CAS
CSCD
北大核心
2015年第3期245-251,共7页
Acta Pharmaceutica Sinica
基金
科技部港澳台国际合作项目资助(2012DFH30030)
关键词
法尼醇X受体
胆汁酸
葡萄糖
脂质
非酒精性脂肪肝
farnesoid X receptor
bile acid
glucose
lipid
non-alcoholic fatty liver diseases